Lipe & Dalton Cooper Companies, Inc. Transaction History

Lipe & Dalton

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	BUY	$306.88 - $380.0 $9,206 - $11,400	30 Added 0.9%	3,360 $1.27 Million
Q2 2023 Jul 26, 2023	SELL	$346.15 - $392.09 $8,653 - $9,802	-25 Reduced 0.75%	3,330 $1.28 Million
Q1 2023 May 02, 2023	SELL	$323.56 - $373.36 $21,031 - $24,268	-65 Reduced 1.9%	3,355 $1.25 Million
Q4 2022 Feb 03, 2023	BUY	$248.67 - $334.17 $13,676 - $18,379	55 Added 1.63%	3,420 $1.13 Million
Q3 2022 Nov 07, 2022	BUY	$263.81 - $337.27 $79,143 - $101,181	300 Added 9.79%	3,365 $888,000
Q2 2022 Aug 01, 2022	BUY	$301.4 - $428.42 $923,790 - $1.31 Million	3,065 New	3,065 $960,000

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Lipe & Dalton, based on Form 13F filings with the SEC.

Stay updated on Lipe & Dalton with notifications on news.